Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
174 participants
INTERVENTIONAL
2024-05-01
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Cholecystectomy is no More Risky in Emergent Cases With in Cardiopulmonary Risk: Fundus-Callot Cholecystectomy With Low Pressure Pneumo-peritoneum VS Open Cholecystectomy
NCT04373447
Emergency Laparoscopic Cholecystectomy With Low Pressure Pneumo-peritoneum in Cardiopulmonary Risk Patients: Fundus First Cholecystectomy VS Calot First Cholecystectomy .
NCT04368611
Fundus-First Laparoscopic Cholecystectomy in Difficult Gallbladders: A Safe Alternative Technique
NCT07113704
Cholecyst- Versus Cystic Duct Cholangiography During Laparoscopic Cholecystectomy
NCT01103570
Laparoscopic Cholecystectomy With Retro-infundibular Approach
NCT02947256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized controlled trial aims to compare the safety and efficacy of fundus-first (FF) versus classical (Calot-first) laparoscopic cholecystectomy techniques in patients with difficult gallbladders. The study will evaluate perioperative outcomes, conversion rates, complications, and operative time between the two surgical approaches. Based on recent evidence suggesting an improved safety profile with the fundus-first technique, we hypothesize that the FF approach will demonstrate reduced bile duct injury rates and improved surgical outcomes in difficult cases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fundus-First Laparoscopic Cholecystectomy ( FFLC)
Laparoscopic cholecystectomy starting dissection at the gallbladder fundus, progressing retrograde toward the cystic duct/artery. Critical View of Safety (CVS) confirmed before duct division.
Fundus-First Laparoscopic Cholecystectomy ( FFLC)
* Standard 4-port laparoscopic setup
* Carbon dioxide (CO₂) pneumoperitoneum (12-15 mmHg)
* Dissection begins at gallbladder fundus
* Peritoneum incised from infundibulum to fundus along liver bed
* Gallbladder dissected from fundus toward infundibulum
* Cystic artery and duct identified and divided last
* Critical view of safety achieved before vessel division
Classical Laparoscopic Cholecystectomy (CLC)
The standard "critical view of safety" technique (anterior-posterior dissection of Calot's triangle first).
Classical Laparoscopic Cholecystectomy (CLC)
* Standard 4-port laparoscopic setup
* Carbon dioxide (CO₂) pneumoperitoneum (12-15 mmHg)
* Dissection begins at Calot's triangle
* Critical view of safety achieved first
* Cystic artery and duct divided before gallbladder bed dissection
* Gallbladder dissected from liver bed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fundus-First Laparoscopic Cholecystectomy ( FFLC)
* Standard 4-port laparoscopic setup
* Carbon dioxide (CO₂) pneumoperitoneum (12-15 mmHg)
* Dissection begins at gallbladder fundus
* Peritoneum incised from infundibulum to fundus along liver bed
* Gallbladder dissected from fundus toward infundibulum
* Cystic artery and duct identified and divided last
* Critical view of safety achieved before vessel division
Classical Laparoscopic Cholecystectomy (CLC)
* Standard 4-port laparoscopic setup
* Carbon dioxide (CO₂) pneumoperitoneum (12-15 mmHg)
* Dissection begins at Calot's triangle
* Critical view of safety achieved first
* Cystic artery and duct divided before gallbladder bed dissection
* Gallbladder dissected from liver bed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptomatic cholelithiasis or cholecystitis requiring laparoscopic cholecystectomy (elective or emergency)
* Difficult gallbladder characteristics: Acute cholecystitis (Tokyo Guidelines 2018 Grade II/III), wall thickness \>4 mm on US, pericholecystic fluid, impacted stone in Hartmann's pouch/cystic duct, previous upper abdominal surgery, BMI \>30 kg/m², ≥3 previous cholecystitis episodes, contracted gallbladder, Mirizzi syndrome Type I/II, empyema, severe pericholecystic adhesions on imaging, suspected anatomical variations
* The American Society of Anesthesiologists (ASA) physical status I-III
* Suitable for laparoscopic approach
* Informed consent
Exclusion Criteria
* Choledocholithiasis requiring endoscopic intervention
* Mirizzi syndrome Grade III-IV
* Gallbladder perforation with generalized peritonitis
* Pregnancy or lactation
* Contraindications to laparoscopy (severe cardiopulmonary disease, coagulopathy)
* Previous biliary or hepatic surgery
* Cirrhosis with portal hypertension
* Active coagulopathy
* Patient refusal
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Saleh Khairy Saleh MD
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saleh K Saleh, MD
Role: PRINCIPAL_INVESTIGATOR
Minia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liver and GIT hospital / Minia university
Minya, Minya Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1131/04/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.